Patent details

EN | LT

LT - Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions

EN - Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 9/00
		A61K 47/38
		A61K 31/56
		A61K 31/58
		A61P 11/02
		A61P 5/44

European patent
(11)	Number of the document	1478340
(13)	Kind of document	T
(96)	European patent application number	03737365.1
	Date of filing the European patent application	2003-02-04
(97)	Date of publication of the European application	2004-11-24
(45)	Date of publication and mention of the grant of the patent	2018-09-12
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/GB2003/000504
	Date	2003-02-04

PCT application publication
(87)	Number	WO 2003/066024
	Date	2003-08-14

Priority applications
(30)	Number	Date	Country code
	67020	2002-02-04	US

Inventors
(72)	BIGGADIKE, Keith, GB BUXTON, Ian, CA COOTE, Steven, John, GB NICE, Rosalyn, Kay, GB REED, Kenton, Lewis, CA SAYANI, Amyn, CA SHARMA, Avinash, Chander, CA

Grantee
(73)	Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, GB

Title
(54)	Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
	Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions